Veradigm Inc
OTC:MDRX
Veradigm Inc
Research & Development
Veradigm Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Veradigm Inc
OTC:MDRX
|
Research & Development
-$97.9m
|
CAGR 3-Years
26%
|
CAGR 5-Years
14%
|
CAGR 10-Years
5%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$750.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-29%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$103.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$93m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Research & Development
-$88.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Research & Development
-$54.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Veradigm Inc
Glance View
Veradigm Inc., formerly known as Allscripts Healthcare Solutions, has carved out a distinct niche within the healthcare technology landscape. The company focuses on the dynamic intersection of technology and healthcare, developing an array of solutions aimed at enhancing healthcare delivery and efficiency. Essentially, Veradigm equips medical professionals with tools for electronic health records, practice management, and remote patient monitoring. By leveraging sophisticated information systems, Veradigm helps streamline operations in doctor's offices, hospitals, and healthcare organizations, making it easier for healthcare providers to deliver efficient and effective services. Their products are designed not only to improve clinical workflows but also to enhance patient engagement, ultimately leading to better health outcomes. The revenue model of Veradigm hinges largely on contractual agreements and subscriptions for its software solutions. By offering a range of cloud-based services, the company ensures a steady flow of recurrent income while reducing the need for expensive on-site installations, thus delivering value to both large hospital systems and smaller, private practices. Additionally, Veradigm has diversified its revenue streams through collaborations with pharmaceutical companies, providing data insights and support for research and marketing initiatives. With a persistent focus on innovation and adaptability, Veradigm not only strengthens its foundational business in healthcare IT but also taps into new opportunities within the emerging landscape of digital health and data analytics.
See Also
What is Veradigm Inc's Research & Development?
Research & Development
-97.9m
USD
Based on the financial report for Dec 31, 2022, Veradigm Inc's Research & Development amounts to -97.9m USD.
What is Veradigm Inc's Research & Development growth rate?
Research & Development CAGR 10Y
5%
Over the last year, the Research & Development growth was 49%. The average annual Research & Development growth rates for Veradigm Inc have been 26% over the past three years , 14% over the past five years , and 5% over the past ten years .